| Chalet Village Health And Rehabilitation Center | |
| 1065 Parkway St, Berne, Indiana 46711 | |
| (260) 589-2127 | |
| Name | Chalet Village Health And Rehabilitation Center |
|---|---|
| Location | 1065 Parkway St, Berne, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 80 |
| Occupancy Rate | 29% |
| Medicare ID (CCN) | 155473 |
| Legal Business Name | Witham Memorial Hospital |
| Ownership Type | Government - City/county |
| NPI Number | 1730256991 |
| Organization Name | ADAMS COUNTY MEMORIAL HOSPITAL |
| Doing Business As | ENVIVE OF BERNE |
| Address | 1065 Parkway Street, Berne, IN 46711 |
| Phone Number | 260-589-2127 |
News Archive
Urologix, a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy™ technology to urologists to provide a durable and effective in-office treatment for patients suffering from benign prostatic hyperplasia (BPH), today reported financial results for its fourth quarter ended June 30, 2010 and for fiscal year 2010.
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 435-440(6); DOI: https://doi.org/10.15212/CVIA.2017.0070 Tracy Ashby, DO and Mariam Louis, MD, MSc, FCCP from the University of Florida, Department of Medicine, Jacksonville, FL, USA consider circadian misalignment and cardiovascular risk.
Researchers from the Biological clues of the invasive and metastatic phenotype group of the Bellvitge Biomedical Research Institute (IDIBELL) led by Isabel Fabregat have discovered the relationship between the TGFb signalling pathways and CXCR4 in hepatocellular carcinoma (HCC) .
New research presented at the American College of Rheumatology Annual Meeting in San Diego describes an exciting novel tool utilizing telephone linked technology that shows potential as a low cost approach to improving exercise adherence in patients with knee osteoarthritis.
Rats with erectile dysfunction, or ED, that were injected with a gene therapy vector containing either of two nerve growth factors were able to regain normal function after four weeks, according to a study conducted by University of Pittsburgh School of Medicine researchers.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Urologix, a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy™ technology to urologists to provide a durable and effective in-office treatment for patients suffering from benign prostatic hyperplasia (BPH), today reported financial results for its fourth quarter ended June 30, 2010 and for fiscal year 2010.
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 435-440(6); DOI: https://doi.org/10.15212/CVIA.2017.0070 Tracy Ashby, DO and Mariam Louis, MD, MSc, FCCP from the University of Florida, Department of Medicine, Jacksonville, FL, USA consider circadian misalignment and cardiovascular risk.
Researchers from the Biological clues of the invasive and metastatic phenotype group of the Bellvitge Biomedical Research Institute (IDIBELL) led by Isabel Fabregat have discovered the relationship between the TGFb signalling pathways and CXCR4 in hepatocellular carcinoma (HCC) .
New research presented at the American College of Rheumatology Annual Meeting in San Diego describes an exciting novel tool utilizing telephone linked technology that shows potential as a low cost approach to improving exercise adherence in patients with knee osteoarthritis.
Rats with erectile dysfunction, or ED, that were injected with a gene therapy vector containing either of two nerve growth factors were able to regain normal function after four weeks, according to a study conducted by University of Pittsburgh School of Medicine researchers.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.99 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.14 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 78 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.03 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 23.26 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.03 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 83.51 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.28 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 68.75 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 4.35 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 7.57 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.86 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.64 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |